Salspera
SciencePipelineOur DataTeamNews & PublicationsFAQContact
  1. FAQ
  2. ›
  3. Pipeline & regulatory

Does Salspera, Inc. have a platform beyond Saltikva?

Yes. Salspera has further programs, including non-cancer indications, that it has not publicly disclosed. Interested parties can contact the company through the contact form on its website.

Still have a question?Contact us →
  • Salspera, Inc. Form S-1/A No. 3, filed 2026-03-20 ↗
  • Salspera Contact page
All questions in this categoryAll 65 questions
SalsperaA privately held, privately funded biopharma company developing Saltikva® and a pipeline of microbial immunotherapies for solid tumors.
CompanyScienceOur DataPipelineTeam
UpdatesNews & PublicationsFAQContactmedia@salspera.com
Legal© 2026 Salspera, Inc. All rights reserved. Saltikva® is a registered trademark of Salspera, Inc. Saltikva® is an investigational therapy and has not been approved by any regulatory authority. Clinical results are from a single-arm, non-randomized study. Statements about future plans are forward-looking.